What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.33%Above 5Y avg (1.18%)
Annual Rate
USD 1.62Paid quarterly
Payout Ratio
58.0%Sustainable
Consecutive Growth
20 yrStrong track record
Paying Dividends
27 yr
Payback Period
88.4 yr
Last Ex-Dividend
Jun 12, 2026
Last Payment
Jul 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.09BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Revenue (TTM)
5.49BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Profit Margin
-4.24%
vs Specialty Chemicals peers
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -7.27%.Updated Jul 17, 2026
Beta
1.35x
vs all stocks
Updated Jul 17, 2026
52-Week Change
58.22%
vs all stocks
Updated Jul 17, 2026
Forward Annual Dividend Yield
1.33%
vs all stocks
Updated Jul 17, 2026
Market Capitalization
14.09BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Enterprise Value
18.12BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Forward P/E
9.59x
vs Specialty Chemicals peers
Updated Jul 17, 2026
Price to Sales (TTM)
2.68x
vs Specialty Chemicals peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 2.56×.Updated Jul 17, 2026
Price to Book (MRQ)
1.93x
vs Specialty Chemicals peers
Updated Jul 17, 2026
Enterprise to Revenue
3.30x
vs Specialty Chemicals peers
Updated Jul 17, 2026
Enterprise to EBITDA
16.97x
vs Specialty Chemicals peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.12×.Updated Jul 17, 2026
Gross Margin
35.06%
vs Specialty Chemicals peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 18.53%.Updated Jul 17, 2026
Profit Margin
-4.24%
vs Specialty Chemicals peers
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -7.27%.Updated Jul 17, 2026
Operating Margin
24.79%
vs Specialty Chemicals peers
Updated Jul 17, 2026
Return on Assets (TTM)
1.60%
vs Specialty Chemicals peers
Updated Jul 17, 2026
Return on Equity (TTM)
-1.82%
vs Specialty Chemicals peers
Updated Jul 17, 2026
Revenue (TTM)
5.49BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Revenue per Share (TTM)
46.67USDUpdated Jul 17, 2026
Quarterly Revenue Growth
32.70%
vs Specialty Chemicals peers
Updated Jul 17, 2026
Gross Profit (TTM)
1.02BUSD
vs all stocks (USD)
Updated Jul 17, 2026
EBITDA (TTM)
1.12BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Net Income (TTM)
-399.64MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Quarterly Earnings Growth (YoY)
671.70%
vs Specialty Chemicals peers
Updated Jul 17, 2026
Operating Cash Flow (TTM)
1.08BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Levered Free Cash Flow (TTM)
716.71MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Forward Annual Dividend Rate
1.62USDUpdated Jul 17, 2026
Forward Annual Dividend Yield
1.33%
vs all stocks
Updated Jul 17, 2026
Trailing Annual Dividend Rate
1.62USDUpdated Jul 17, 2026
Trailing Annual Dividend Yield
1.33%
vs all stocks
Updated Jul 17, 2026
5-Year Average Dividend Yield
1.18%
vs all stocks
Updated Jul 17, 2026
Payout Ratio
57.97%
vs Specialty Chemicals peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -48.8%.Updated Jul 17, 2026
Minority Interest (Equity)
248.10MUSDFY2025 · Dec 31, 2025
Revenue
5.14BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
4.47BUSDFY2025 · Dec 31, 2025
Gross Profit
668.72MUSDFY2025 · Dec 31, 2025
Operating Income
67.28MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-552.07MUSDFY2025 · Dec 31, 2025
Income Tax Expense
156.88MUSDFY2025 · Dec 31, 2025
Net Income
-465.21MUSDFY2025 · Dec 31, 2025
EBIT
-344.42MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
748.63MUSDFY2025 · Dec 31, 2025
Research & Development
51.40MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
550.04MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
207.65MUSDFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-465.21MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
-45.42MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
1.05BUSDFY2025 · Dec 31, 2025
Free Cash Flow
1.01BUSDDerived from operating cash flow minus capital expenditure. This filing charges 658.68M of depreciation against 32.81M of capital expenditure, and its own free-cash-flow line reads 692.47M.FY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.62BUSDFY2025 · Dec 31, 2025
Income Tax Paid
152.48MUSDFY2025 · Dec 31, 2025
Interest Paid
180.71MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-465.21MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
658.68MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
81.17MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
40.27MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
47.31MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
128.15MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
555.67MUSDFY2025 · Dec 31, 2025
Capital Expenditures
32.81MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-239.00KUSDFY2025 · Dec 31, 2025
Sale of Investments
411.22MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
443.79MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
56.73MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-511.39MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
-357.28MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-25.48MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-837.43MUSDFY2025 · Dec 31, 2025
Shares Outstanding
117.89MSharesUpdated Jul 17, 2026
Float Shares
117.54MSharesUpdated Jul 17, 2026
Shares Short
70.43KSharesUpdated Jul 17, 2026
Short Ratio
0.0300days
vs all stocks
Updated Jul 17, 2026
Short % of Shares Outstanding
0.07%
vs all stocks
Updated Jul 17, 2026
% Held by Insiders
0.19%
vs all stocks
Updated Jul 17, 2026
% Held by Institutions
96.28%
vs all stocks
Updated Jul 17, 2026
Total Cash (MRQ)
1.09BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Total Cash per Share (MRQ)
9.24USDUpdated Jul 17, 2026
Total Debt (MRQ)
2.01BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Total Debt to Equity (MRQ)
0.1984x
vs Specialty Chemicals peers
Updated Jul 17, 2026
Current Ratio (MRQ)
2.07x
vs Specialty Chemicals peers
Updated Jul 17, 2026
Book Value per Share (MRQ)
64.60USDUpdated Jul 17, 2026
Total Assets
16.37BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.01BUSDFY2025 · Dec 31, 2025
Total Liabilities
6.59BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
12.37BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.79BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.80BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.62BUSDFY2025 · Dec 31, 2025
Accounts Receivable
593.50MUSDFY2025 · Dec 31, 2025
Inventory
1.18BUSDFY2025 · Dec 31, 2025
Accounts Payable
913.53MUSDFY2025 · Dec 31, 2025
Short-term Debt
74.08MUSDFY2025 · Dec 31, 2025
Deferred Revenue
93.09MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
191.75MUSDFY2025 · Dec 31, 2025
Long-term Debt
3.22BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
68.86MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
1.18MUSDFY2025 · Dec 31, 2025
Retained Earnings
4.61BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
9.78BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
64.95USDUpdated Jul 17, 2026
52-Week High
221.00USDUpdated Jul 17, 2026
52-Week Change
58.22%
vs all stocks
Updated Jul 17, 2026
Beta
1.35x
vs all stocks
Updated Jul 17, 2026
50-Day MA
161.89USDUpdated Jul 17, 2026
200-Day MA
150.84USDUpdated Jul 17, 2026
Avg 10-Day Volume
1.83MSharesUpdated Jul 17, 2026
Avg 30-Day Volume
2.38MSharesUpdated Jul 17, 2026
Diluted EPS (TTM)
-3.32USDUpdated Jul 17, 2026
Other Income / Expense
-411.71MUSDFY2025 · Dec 31, 2025
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.08: grey zoneSignificant
Altman Z-Score: 2.08
High earnings qualityNotable
Earnings Quality Score: 0.64
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $14.09B, above the global median of $1.15BNotable
Market cap (USD): 14,088,473,408Global Median: 1,146,734,693.424
Revenue is $5.49B, above the global median of $520.53MNotable